Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.32 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.32 |
| ▸ | NOS3 | P29474 | 1/20 | 0.31 |
| ▸ | NOS1 | P29475 | 1/20 | 0.31 |
| ▸ | NOS2 | P35228 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22980719 | 1.00 | ALDH1A1 (0.35) | ALDH1A1CHRNB2CHRNA4NOS3NOS1 | |
| SCHEMBL31412448 | 0.83 | ALDH1A1 (0.35) | ALDH1A1CHRNB2CHRNA4LMNA | |
| SCHEMBL13521756 | 0.83 | ALDH1A1 (0.35) | ALDH1A1CHRNB2CHRNA4LMNA | |
| SCHEMBL29878553 | 0.79 | CYP1A2 (0.42) | ALDH1A1CHRNB2CHRNA4NOS3NOS1 | |
| SCHEMBL5118435 | 0.79 | CYP1A2 (0.42) | ALDH1A1CHRNB2CHRNA4NOS3NOS1 | |
| SCHEMBL17053139 | 0.78 | UHRF1 (0.41) | NOS3NOS1NOS2 | |
| SCHEMBL13909495 | 0.76 | — | — | |
| SCHEMBL31252016 | 0.75 | ALDH1A1 (0.31) | ALDH1A1 | |
| SCHEMBL26984273 | 0.75 | ALDH1A1 (0.35) | ALDH1A1 | |
| SCHEMBL31555805 | 0.74 | ALDH1A1 (0.38) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4010080-A1 | HETEROCYCLIC COMPOUNDS FOR USE IN THE TREATMENT OF CANCER | Artios Pharma Limited (GB) | 2022-06-15 | — | — | EP | disclosed |